Results 251 to 260 of about 5,678,918 (297)

Targeting the Enhanced Sensitivity of Radiotherapy in Cancer: Mechanisms, Applications, and Challenges

MedComm, Volume 6, Issue 6, June 2025.
In this review, we first introduced the current application scenarios for radiotherapy in tumor treatment, the molecular mechanisms underlying anticancer effects of radiotherapy in treatment of cancer, and the side‐effects of radiotherapy. Second, we pay attention to discuss the main types of radiosensitizers and their latest applications and ...
Yuanyuan Zhao, Fangqin Tan, Jiajia Zhao, Shuchang Zhou, Yao Luo, Chen Gong   +5 more
wiley   +1 more source

Modern Approach to Nodal T-Cell Lymphomas. [PDF]

Adv Anat Pathol
Ondrejka SL, de Leval L, de Leval L.
europepmc   +1 more source

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B‐Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling

MedComm, Volume 6, Issue 6, June 2025.
This prospective study evaluates hypofractionated radiotherapy combined with zimberelimab in primary refractory DLBCL. A 61.5% complete response rate was achieved in the first stage. Digital spatial profiling analysis revealed T cell–lymphoma interactions and linked T cell infiltration to resistance.
Yong Yang, Jing Yu, Xiao‐Mei Hu, Si‐Lin Chen, Rui‐Zhi Zhao, Cheng Huang, Jiang‐Rui Guo, Tian‐Lan Tang, Cheng Chen, Yu‐Ping Lin, Ying Wang, Tian‐Xiu Liu, Hao Zheng, Si‐Qin Liao, Jin‐Hua Chen, Hai‐Ying Fu, Ting‐Bo Liu   +16 more
wiley   +1 more source

Epiglottal involvement of mycosis fungoides. [PDF]

JAAD Case Rep
Mercante MG, Tocco EG, DeSimone J.
europepmc   +1 more source

A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer

The Journal of Pathology, Volume 266, Issue 2, Page 192-203, June 2025.
Abstract Microsatellite instability is a strong predictor of response to immune checkpoint therapy and patient outcome in colorectal cancer. Although enrichment of distinct T‐cell subpopulations has been determined to impact the response to immune checkpoint therapy and patient outcome, little is known about the underlying changes in the composition of
Zhihao Huang, Tim Mandelkow, Nicolaus F Debatin, Magalie C J Lurati, Julia Ebner, Jonas B Raedler, Elena Bady, Jan H Müller, Ronald Simon, Eik Vettorazzi, Anne Menz, Katharina Möller, Natalia Gorbokon, Guido Sauter, Maximilian Lennartz, Andreas M Luebke, Doris Höflmayer, Till Krech, Patrick Lebok, Christoph Fraune, Andrea Hinsch, Frank Jacobsen, Andreas H Marx, Stefan Steurer, Sarah Minner, David Dum, Sören Weidemann, Christian Bernreuther, Till S Clauditz, Eike Burandt, Niclas C Blessin   +30 more
wiley   +1 more source

Discrepancy of Hans' criteria for clonally related nodal and pericardiac fluid diffuse large B-cell lymphoma with MYD88 L265P mutation. [PDF]

J Clin Exp Hematop
Terao T, Sato Y, Kuroda Y, Haratake T, Nishimura MF, Sato Y, Kuyama S.   +6 more
europepmc   +1 more source

Immunotherapy for resectable lung cancer

Cancer, Volume 131, Issue 10, 15 May 2025.
Abstract Lung cancer remains a significant global health challenge, demanding innovative treatment strategies. Immune checkpoint blockade has revolutionized cancer care, leading to improved survival across advanced malignancies and has now become a standard therapy for earlier stage, resectable lung cancer.
Colum Dennehy, Michael R. Conroy, Patrick M. Forde   +2 more
wiley   +1 more source

Functional characterization of the UBIAD1 protein: The nodal point for vitamin K and cholesterol synthesis. From corneal dystrophies to lifestyle diseases

, 2018
Anna Sarosiak, Monika Ołdak, Monika Ołdak   +2 more
openalex   +1 more source

A Fluorescent Aptasensor for Sensitive and Selective Determination of Epigenetic Cancer Biomarker N1‐Methyladenosine in Urine Samples

Chemistry – A European Journal, Volume 31, Issue 27, May 14, 2025.
Using N1‐methyladenosine, a cancer biomarker as a target, a highly selective DNA aptamer was obtained with excellent selectivity and affinity, allowing the detection with a limit of detection of 1.9 µm. Abstract N1‐methyladenosine (m1A) level in urine increases in the presence of cancer and is associated with the tumor size and stage.
Esra Bağda, Efkan Bağda, Juewen Liu
wiley   +1 more source

Single-Cell RNA-Seq Recognized Key Genes for Metastasis and Macrophage Infiltration in Colorectal Cancer. [PDF]

Hum Mutat
Shi J, Zheng P, Ouyang L, Cui F.
europepmc   +1 more source